Sponsor

Beaumont Hospital

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Beaumont Hospital appears in 20 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials20
Recruiting shown2
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

20 shown
Evaluation of Wellbeing and Patient Reported Outcomes After Open vs Robotic Mastectomy With DIEP ReconstructionNCT07230535 · lead sponsor · 2025-12-01
RECRUITING
Evaluation of Well Being and Patient Reported Outcomes After Robotic Single-port Nipple Sparing Mastectomy and Implant ReconstructionNCT07236359 · lead sponsor · 2025-12-31
NOT_YET_RECRUITING
A Retrospective Study to Evaluate the Predictability of Abnormal Arterial Blood Gas Measurements Through Novel Observations of Continuous Trends in Electronically Measured Respiratory Rate in a Mixed Cohort of Respiratory Compromised PatientsNCT05384314 · lead sponsor · 2021-07-12
UNKNOWN
Effectiveness of Vibrating Mesh Versus Small Volume Nebuliser in Chronic Obstructive Pulmonary Disease (COPD)NCT03286855 · lead sponsor · 2017-10-18
COMPLETED
A Pilot Comparison Study of Vibrating Mesh Versus Standard Jet Nebuliser for Bronchodilator Delivery in COPDNCT02686086 · lead sponsor · 2016-02-01
COMPLETED
Inhaler Adherence in Severe Unstable AsthmaNCT02307669 · lead sponsor · 2015-12-01
UNKNOWN
Preventing Repeat Hospitalisations in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT02644772 · lead sponsor · 2015-10-01
COMPLETED
Dose Dense Chemotherapy With Lipegfilgrastim Support in Early Breast CancerNCT02527317 · lead sponsor · 2015-01-01
COMPLETED
Seasonal Trends in Pneumococcal Carriage in COPD PatientsNCT02535546 · lead sponsor · 2014-07-01
COMPLETED
Teaching Inhaler Use With the INCA Device in a Community Pharmacy SettingNCT02203266 · lead sponsor · 2014-02-01
COMPLETED
A Study of Inhaler Use in the CommunityNCT02552472 · lead sponsor · 2012-08-01
COMPLETED
Objective Assessment of Adherence to Inhalers by COPD PatientsNCT04025242 · lead sponsor · 2012-02-01
COMPLETED
Prospective Study of the Feedback From an Adherence Monitor on Asthma ControlNCT01529697 · lead sponsor · 2012-02-01
COMPLETED
Long-term Impact of Pulmonary RehabilitationNCT00959855 · lead sponsor · 2009-09-01
COMPLETED
Acupuncture Combined With Pulmonary Rehabilitation: Are There Additional Benefits?NCT01112943 · lead sponsor · 2007-07-01
COMPLETED
Long Term Evaluation of Activity Levels Post Pulmonary RehabilitationNCT01530412 · lead sponsor · 2007-06-01
COMPLETED
Stereotactic Ablative Radiotherapy for OligoMetastatic Breast CancerNCT05377047 · collaborator · 2022-09-19
RECRUITING
Alendronate for Prevention of AntiRetroviral Therapy-associated Bone LossNCT02322099 · collaborator · 2016-05-01
TERMINATED
Chronic Hypertension and Pregnancy (CHAP) ProjectNCT02299414 · collaborator · 2015-06-01
COMPLETED
The All Ireland Infectious Diseases Cohort ProjectNCT06410053 · collaborator · 2011-03-01
UNKNOWN

Drugs studied in this sponsor's trials

4 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Beaumont Hospital as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
alendronate1
lipegfilgrastim1
placebo1
tenofovir disoproxil1

Sponsor roles

lead sponsor16
collaborator4
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.